{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T20:39:44Z","timestamp":1781123984048,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T00:00:00Z","timestamp":1489449600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T00:00:00Z","timestamp":1489449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P50 AR060772"],"award-info":[{"award-number":["P50 AR060772"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12872-017-0513-6","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T03:08:31Z","timestamp":1489460911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes"],"prefix":"10.1186","volume":"17","author":[{"given":"Jasvinder A.","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha","family":"Ramachandaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,14]]},"reference":[{"issue":"8","key":"513_CR1","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1002\/art.22014","volume":"54","author":"E Krishnan","year":"2006","unstructured":"Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis Rheum. 2006;54(8):2688\u201396.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"513_CR2","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1136\/ard.2009.122770","volume":"69","author":"MA De Vera","year":"2010","unstructured":"De Vera MA, Rahman MM, Bhole V, Kopec JA, Choi HK. Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study. Ann Rheum Dis. 2010;69(6):1162\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"513_CR3","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1093\/rheumatology\/ket293","volume":"52","author":"OO Seminog","year":"2013","unstructured":"Seminog OO, Goldacre MJ. Gout as a risk factor for myocardial infarction and stroke in England: evidence from record linkage studies. Rheumatology (Oxford). 2013;52(12):2251\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"513_CR4","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1161\/01.HYP.0000069700.62727.C5","volume":"41","author":"RJ Johnson","year":"2003","unstructured":"Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003;41(6):1183\u201390.","journal-title":"Hypertension"},{"issue":"7","key":"513_CR5","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/art.24612","volume":"61","author":"SY Kim","year":"2009","unstructured":"Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum. 2009;61(7):885\u201392.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"513_CR6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/acr.20065","volume":"62","author":"SY Kim","year":"2010","unstructured":"Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2010;62(2):170\u201380.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"17","key":"513_CR7","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMra0800885","volume":"359","author":"DI Feig","year":"2008","unstructured":"Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359(17):1811\u201321.","journal-title":"N Engl J Med"},{"issue":"1","key":"513_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1124\/pr.58.1.6","volume":"58","author":"P Pacher","year":"2006","unstructured":"Pacher P, Nivorozhkin A, Szabo C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev. 2006;58(1):87\u2013114.","journal-title":"Pharmacol Rev"},{"issue":"3A","key":"513_CR9","doi-asserted-by":"publisher","first-page":"7A","DOI":"10.1016\/S0002-9149(02)03144-2","volume":"91","author":"D Harrison","year":"2003","unstructured":"Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol. 2003;91(3A):7A\u201311.","journal-title":"Am J Cardiol"},{"issue":"21","key":"513_CR10","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1136\/heartjnl-2012-302249","volume":"98","author":"A Struthers","year":"2012","unstructured":"Struthers A, Shearer F. Allopurinol: novel indications in cardiovascular disease. Heart. 2012;98(21):1543\u20135.","journal-title":"Heart"},{"issue":"6","key":"513_CR11","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/CRD.0b013e318229a908","volume":"19","author":"A Kelkar","year":"2011","unstructured":"Kelkar A, Kuo A, Frishman WH. Allopurinol as a cardiovascular drug. Cardiol Rev. 2011;19(6):265\u201371.","journal-title":"Cardiol Rev"},{"key":"513_CR12","doi-asserted-by":"crossref","unstructured":"Grimaldi-Bensouda L, Alperovitch A, Aubrun E, Danchin N, Rossignol M, Abenhaim L, et al. Impact of allopurinol on risk of myocardial infarction. Ann Rheum Dis. 2015;74:836\u201342.","DOI":"10.1136\/annrheumdis-2012-202972"},{"issue":"9","key":"513_CR13","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1136\/heartjnl-2014-306670","volume":"101","author":"FJ de Abajo","year":"2015","unstructured":"de Abajo FJ, Gil MJ, Rodriguez A, Garcia-Poza P, Alvarez A, Bryant V, Garcia-Rodriguez LA. Allopurinol use and risk of non-fatal acute myocardial infarction. Heart. 2015;101(9):679\u201385.","journal-title":"Heart"},{"issue":"4","key":"513_CR14","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/j.1365-2125.2010.03887.x","volume":"71","author":"L Wei","year":"2011","unstructured":"Wei L, Mackenzie IS, Chen Y, Struthers AD, MacDonald TM. Impact of allopurinol use on urate concentration and cardiovascular outcome. Br J Clin Pharmacol. 2011;71(4):600\u20137.","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"513_CR15","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/aje\/kwg231","volume":"158","author":"WA Ray","year":"2003","unstructured":"Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol. 2003;158(9):915\u201320.","journal-title":"Am J Epidemiol"},{"issue":"7","key":"513_CR16","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.amjmed.2011.09.033","volume":"125","author":"Y Zhu","year":"2012","unstructured":"Zhu Y, Pandya BJ, Choi HK. Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007\u20132008. Am J Med. 2012;125(7):679\u201387. e671.","journal-title":"Am J Med"},{"issue":"2","key":"513_CR17","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1046\/j.1524-4733.2003.00215.x","volume":"6","author":"CC Kamath","year":"2003","unstructured":"Kamath CC, Kremers HM, Vanness DJ, O'Fallon WM, Cabanela RL, Gabriel SE. The cost-effectiveness of acetaminophen, NSAIDs, and selective COX-2 inhibitors in the treatment of symptomatic knee osteoarthritis. Value Health. 2003;6(2):144\u201357.","journal-title":"Value Health"},{"key":"513_CR18","unstructured":"STROBE Statement. Strengthening the reporting of observational studies in epidemiology. Link: http:\/\/www.strobe-statement.org\/fileadmin\/Strobe\/uploads\/checklists\/STROBE_checklist_v4_cohort.pdf . Accessed 28 Feb 2017."},{"issue":"5","key":"513_CR19","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/art.22767","volume":"57","author":"JA Singh","year":"2007","unstructured":"Singh JA, Hodges JS, Toscano JP, Asch SM. Quality of care for gout in the US needs improvement. Arthritis Rheum. 2007;57(5):822\u20139.","journal-title":"Arthritis Rheum"},{"issue":"Suppl 2","key":"513_CR20","doi-asserted-by":"publisher","first-page":"B10","DOI":"10.2337\/diacare.27.suppl_2.B10","volume":"27","author":"DR Miller","year":"2004","unstructured":"Miller DR, Safford MM, Pogach LM. Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care. 2004;27 Suppl 2:B10\u201321.","journal-title":"Diabetes Care"},{"issue":"4","key":"513_CR21","first-page":"A126","volume":"6","author":"JA Singh","year":"2009","unstructured":"Singh JA. Accuracy of veterans affairs databases for diagnoses of chronic diseases. Prev Chronic Dis. 2009;6(4):A126.","journal-title":"Prev Chronic Dis"},{"issue":"4","key":"513_CR22","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1177\/1062860606288243","volume":"21","author":"LI Solberg","year":"2006","unstructured":"Solberg LI, Engebretson KI, Sperl-Hillen JM, Hroscikoski MC, O'Connor PJ. Are claims data accurate enough to identify patients for performance measures or quality improvement? The case of diabetes, heart disease, and depression. Am J Med Qual. 2006;21(4):238\u201345.","journal-title":"Am J Med Qual"},{"issue":"5","key":"513_CR23","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1097\/01.mlr.0000160417.39497.a9","volume":"43","author":"E Birman-Deych","year":"2005","unstructured":"Birman-Deych E, Waterman AD, Yan Y, Nilasena DS, Radford MJ, Gage BF. Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors. Med Care. 2005;43(5):480\u20135.","journal-title":"Med Care"},{"issue":"1","key":"513_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ahj.2004.02.013","volume":"148","author":"Y Kiyota","year":"2004","unstructured":"Kiyota Y, Schneeweiss S, Glynn RJ, Cannuscio CC, Avorn J, Solomon DH. Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J. 2004;148(1):99\u2013104.","journal-title":"Am Heart J"},{"issue":"1","key":"513_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1161\/CIRCOUTCOMES.113.000371","volume":"8","author":"JL Thigpen","year":"2015","unstructured":"Thigpen JL, Dillon C, Forster KB, Henault L, Quinn EK, Tripodis Y, Berger PB, Hylek EM, Limdi NA. Validity of international classification of disease codes to identify ischemic stroke and intracranial hemorrhage among individuals with associated diagnosis of atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2015;8(1):8\u201314.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"7","key":"513_CR26","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.3899\/jrheum.111533","volume":"39","author":"DB Crittenden","year":"2012","unstructured":"Crittenden DB, Lehmann RA, Schneck L, Keenan RT, Shah B, Greenberg JD, Cronstein BN, Sedlis SP, Pillinger MH. Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout. J Rheumatol. 2012;39(7):1458\u201364.","journal-title":"J Rheumatol"},{"issue":"12","key":"513_CR27","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1161\/STROKEAHA.108.519793","volume":"39","author":"SW Muir","year":"2008","unstructured":"Muir SW, Harrow C, Dawson J, Lees KR, Weir CJ, Sattar N, Walters MR. Allopurinol use yields potentially beneficial effects on inflammatory indices in those with recent ischemic stroke: a randomized, double-blind, placebo-controlled trial. Stroke. 2008;39(12):3303\u20137.","journal-title":"Stroke"},{"issue":"8","key":"513_CR28","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.2215\/CJN.11451210","volume":"6","author":"M Kanbay","year":"2011","unstructured":"Kanbay M, Huddam B, Azak A, Solak Y, Kadioglu GK, Kirbas I, Duranay M, Covic A, Johnson RJ. A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol. 2011;6(8):1887\u201394.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"513_CR29","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s00392-007-0636-3","volume":"97","author":"O Yiginer","year":"2008","unstructured":"Yiginer O, Ozcelik F, Inanc T, Aparci M, Ozmen N, Cingozbay BY, Kardesoglu E, Suleymanoglu S, Sener G, Cebeci BS. Allopurinol improves endothelial function and reduces oxidant-inflammatory enzyme of myeloperoxidase in metabolic syndrome. Clin Res Cardiol. 2008;97(5):334\u201340.","journal-title":"Clin Res Cardiol"},{"issue":"4","key":"513_CR30","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1159\/000360609","volume":"39","author":"M Kanbay","year":"2014","unstructured":"Kanbay M, Siriopol D, Nistor I, Elcioglu OC, Telci O, Takir M, Johnson RJ, Covic A. Effects of allopurinol on endothelial dysfunction: a meta-analysis. Am J Nephrol. 2014;39(4):348\u201356.","journal-title":"Am J Nephrol"},{"issue":"1","key":"513_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/07435800.2011.566235","volume":"37","author":"G Melendez-Ramirez","year":"2012","unstructured":"Melendez-Ramirez G, Perez-Mendez O, Lopez-Osorio C, Kuri-Alfaro J, Espinola-Zavaleta N. Effect of the treatment with allopurinol on the endothelial function in patients with hyperuricemia. Endocr Res. 2012;37(1):1\u20136.","journal-title":"Endocr Res"},{"issue":"7","key":"513_CR32","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1681\/ASN.2010111185","volume":"22","author":"MP Kao","year":"2011","unstructured":"Kao MP, Ang DS, Gandy SJ, Nadir MA, Houston JG, Lang CC, Struthers AD. Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease. J Am Soc Nephrol. 2011;22(7):1382\u20139.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"513_CR33","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3109\/08037051.2010.538977","volume":"20","author":"A Dogan","year":"2011","unstructured":"Dogan A, Yarlioglues M, Kaya MG, Karadag Z, Dogan S, Ardic I, Dogdu O, Kilinc Y, Zencir C, Akpek M, et al. Effect of long-term and high-dose allopurinol therapy on endothelial function in normotensive diabetic patients. Blood Press. 2011;20(3):182\u20137.","journal-title":"Blood Press"},{"key":"513_CR34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ijcard.2015.08.086","volume":"213","author":"S Biscaglia","year":"2016","unstructured":"Biscaglia S, Ceconi C, Malagu M, Pavasini R, Ferrari R. Uric acid and coronary artery disease: an elusive link deserving further attention. Int J Cardiol. 2016;213:28\u201332.","journal-title":"Int J Cardiol"},{"key":"513_CR35","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1053\/j.ajkd.2014.11.016","volume":"65","author":"M Goicoechea","year":"2015","unstructured":"Goicoechea M, Garcia de Vinuesa S, Verdalles U, Verde E, Macias N, Santos A, Perez de Jose A, Cedeno S, Linares T, Luno J. Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial. Am J Kidney Dis. 2015;65:543\u20139.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"513_CR36","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10157-012-0742-z","volume":"17","author":"H Terawaki","year":"2013","unstructured":"Terawaki H, Nakayama M, Miyazawa E, Murata Y, Nakayama K, Matsushima M, Miyazaki M, Sato H, Sato M, Sato T, et al. Effect of allopurinol on cardiovascular incidence among hypertensive nephropathy patients: the Gonryo study. Clin Exp Nephrol. 2013;17(4):549\u201353.","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"513_CR37","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3899\/jrheum.140588","volume":"42","author":"N Rashid","year":"2015","unstructured":"Rashid N, Coburn BW, Wu YL, Cheetham TC, Curtis JR, Saag KG, Mikuls TR. Modifiable factors associated with allopurinol adherence and outcomes among patients with gout in an integrated healthcare system. J Rheumatol. 2015;42(3):504\u201312.","journal-title":"J Rheumatol"},{"issue":"2","key":"513_CR38","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3810\/pgm.2014.03.2741","volume":"126","author":"H Hatoum","year":"2014","unstructured":"Hatoum H, Khanna D, Lin SJ, Akhras KS, Shiozawa A, Khanna P. Achieving serum urate goal: a comparative effectiveness study between allopurinol and febuxostat. Postgrad Med. 2014;126(2):65\u201375.","journal-title":"Postgrad Med"},{"issue":"1","key":"513_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pds.3334","volume":"22","author":"ES Johnson","year":"2013","unstructured":"Johnson ES, Bartman BA, Briesacher BA, Fleming NS, Gerhard T, Kornegay CJ, Nourjah P, Sauer B, Schumock GT, Sedrakyan A, et al. The incident user design in comparative effectiveness research. Pharmacoepidemiol Drug Saf. 2013;22(1):1\u20136.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"513_CR40","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/pds.1926","volume":"19","author":"S Schneeweiss","year":"2010","unstructured":"Schneeweiss S. A basic study design for expedited safety signal evaluation based on electronic healthcare data. Pharmacoepidemiol Drug Saf. 2010;19(8):858\u201368.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"24","key":"513_CR41","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1001\/jama.2011.878","volume":"305","author":"DH Solomon","year":"2011","unstructured":"Solomon DH, Massarotti E, Garg R, Liu J, Canning C, Schneeweiss S. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. JAMA. 2011;305(24):2525\u201331.","journal-title":"JAMA"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-017-0513-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-017-0513-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-017-0513-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T23:28:56Z","timestamp":1719098936000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-017-0513-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,14]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["513"],"URL":"https:\/\/doi.org\/10.1186\/s12872-017-0513-6","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,14]]},"assertion":[{"value":"6 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"76"}}